Wall Street rally pauses after underwhelming revenue forecasts
February 6, 2019At least four pharma CEOs to testify at Senate drug pricing hearing
February 6, 2019Novartis CEO says U.S. rebate plan will return cash to patients
at
Novartis AG Chief Executive Vas Narasimhan said his company’s prescription drug prices have been “flat to negative” over the last three years, and directed blame for high costs for U.S. patients on industry middlemen that manage drug benefits.
Powered by WPeMatico
